Oral green tea catechins transiently lower plasma glucose concentrations in female db/db mice

Journal of Medicinal Food

Volumn 16, Issue 4, 2013, Pages 312-317

  Wein, Silvia ^a   Schrader, Eva ^a   Rimbach, Gerald ^a   Wolffram, Siegfried ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

adiponectin; db db mice; epigallocatechin gallate; flavonoids; green tea extract; inflammation; insulin resistance; obesity

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOBESITY AGENT; CATECHIN; CHOLESTEROL; FATTY ACID; FLAVONOID; GLUCOSE; GREEN TEA EXTRACT; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; ROSIGLITAZONE; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOSE RESPONSE; ENDOTHELIUM CELL; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; LIVER; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; TEA; WEIGHT GAIN;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; CAMELLIA SINENSIS; CATECHIN; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; FLAVONOIDS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, KNOCKOUT; MICE, OBESE; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

MUS;

EID: 84876121880     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.0205     Document Type: Article

References (43)

1. Visscher TLS, Seidell JC: The public health impact of obesity. Annu Rev Publ Health 2001;22:355-375
2. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
3. Aljada A, Shah KA, Mousa SA: Peroxisome proliferator-Activated receptor agonists: Do they increase cardiovascular. PPAR Res 2009;2009:460764
4. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VKK, O'Rahilly S: Activators of peroxisome proliferator-Activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 1997;100:3149-3153
5. Viner RM, Hsia Y, Tomsic T, Wong ICK: Efficacy and safety of anti-obesity drugs in children and adolescents: Systematic review and meta-Analysis. Obes Rev 2010;11:593-602
6. Kennedy J: Herb and supplement use in the US adult population. Clin Ther 2005;27:1847-1858
7. Middleton E, Kandaswami C, Theoharides TC: The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673-751
8. Egert S, Rimbach G: Which sources of flavonoids: Complex diets or dietary supplements? Adv Nutr 2011;2:8-14
9. Balentine DA, Wiseman SA, Bouwens LC: The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 1997;37:693-704
10. Thielecke F, Boschmann M: The potential role of green tea catechins in the prevention of the metabolic syndrome-A review. Phytochemistry 2009;70:11-24
11. Graham HN: Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334-350
12. Graf BA, Milbury PE, Blumberg JB: Flavonols, flavones, flavanones, and human health: Epidemiological evidence. J Med Food 2005;8:281-290
13. Tipoe GL, Leung TM, Liong EC, Lau TY, Fung ML, Nanji AA: Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. Toxicology 2010;273:45-52
14. Lee AS, Jung YJ, Kim DH, Lee TH, Kang KP, Lee S, Lee NH, Sung MJ, Kwon DY, Park SK, Kim W: Epigallocatechin-3-Ogallate decreases tumor necrosis factor-Alpha-induced fractalkine expression in endothelial cells by suppressing NF-kappaB. Cell Physiol Biochem 2009;24:503-510
15. Wolfram S, Raederstorff D, Wang Y, Teixeira SR, Elste V, Weber P: TEAVIGO (TM) (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann Nutr Metab 2005;49:54-63
16. Ahn HY, Xu Y, Davidge ST: Epigallocatechin-3-O-gallate inhibits TNF alpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells. Life Sci 2008;82: 964-968
17. Shiniada M, Mochizuki K, Sakurai N, Goda T: Dietary supplementation with epigallocatechin gallate elevates levels of circulating adiponectin in non-obese type-2 diabetic goto-kakizaki rats. Biosci Biotech Bioch 2007;71:2079-2082
18. Ueda M, Nishiumi S, Nagayasu H, Fukuda I, Yoshida K, Ashida H: Epigallocatechin gallate promotes GLUT4 translocation in skeletal muscle. Biochem Bioph Res Commun 2008;377: 286-290
19. Johnson PR, Greenwood MRC, Horwitz BA, Stern JS: Animalmodels of obesity-genetic-Aspects. Annu Rev Nutr 1991;11: 325-353
20. Cooper R, Morre DJ, Morre DM: Medicinal benefits of green tea: Part I. Review of noncancer health benefits. J Altern Complem Med 2005;11:521-528
21. Kao YH, Chang HH, Lee MJ, Chen CL: Tea, obesity, and diabetes. Mol Nutr Food Res 2006;50:188-210
22. Wheeler DS, Wheeler WJ: The medicinal chemistry of tea. Drug Develop Res 2004;61:45-65
23. Srinivasan K, Ramarao P: Animal models in type 2 diabetes research: An overview. Indian J Med Res 2007;125:451-472
24. Bhagwat S, Haytowitz DB, Holden JM: USDA Database for the Flavonoid Content of Selected Foods Release 3. Nutrient Data Laboratory, Food Composition Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture. 2011. Beltsville, Maryland 20705, U.S. Department of Agriculture
25. Baer DJ, Novotny JA, Harris GK, Stote K, Clevidence B, Rumpler WV: Oolong tea does not improve glucose metabolism in non-diabetic adults. Eur J Clin Nutr 2011;65:87-93
26. Brown AL, Lane J, Coverly J, Stocks J, Jackson S, Stephen A, Bluck L, Coward A, Hendrickx H: Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: Randomized controlled trial. Br J Nutr 2009;101:886-894
27. Nahas R, Moher M: Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician 2009;55: 591-596
28. Josic J, Olsson AT, Wickeberg J, Lindstedt S, Hlebowicz J: Does green tea affect postprandial glucose, insulin and satiety in healthy subjects: A randomized controlled trial. Nutr J 2010;9:63
29. Chien PJ, Chen YC, Lu SC, Sheu F: Dietary flavonoids suppress adipogenesis in 3T3-L1 preadipocytes. J Food Drug Anal 2005; 13:168-175
30. Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J, Park OJ: Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-Activated protein kinase. Biochem Bioph Res Commun 2005;338:694-699
31. Lin J, Della-Fera MA, Baile CA: Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obes Res 2005;13:982-990
32. Sotiropoulos KB, Clermont A, Yasuda Y, Rask-Madsen C, Mastumoto M, Takahashi J, Della VK, Kondo T, Aiello LP, King GL: Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: Novel mechanism for PPARgamma agonist's effects on edema and weight gain. FASEB J 2006;20:1203-1205
33. Kao YH, Hiipakka RA, Liao SS: Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 2000;141:980-987
34. Kadowaki T: Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116:1784-1792
35. Constans J, Conri C: Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 2006;368:33-47
36. Gearing AJH, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ: Soluble forms of vascular adhesion molecules, Eselectin, Icam-1, and Vcam-1-pathological Significance. Ann NY Acad Sci 1992;667:324-331
37. Hammarstedt A, Andersson CX, Rotter S, V, Smith U: The effect of PPARgamma ligands on the adipose tissue in insulin resistance. Prostaglandins Leukot Essent Fatty Acids 2005;73:65-75
38. Moore GB, Chapman H, Holder JC, Lister CA, Piercy V, Smith SA, Clapham JC: Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice. Biochem Biophys Res Commun 2001;286:735-741
39. Suzuki A, Yasuno T, Kojo H, Hirosumi J, Mutoh S, Notsu Y: Alteration in expression profiles of a series of diabetes-related genes in db/db mice following treatment with thiazolidinediones. Jpn J Pharmacol 2000;84:113-123
40. Shin HY, Kim SH, Jeong HJ, Kim SY, Shin TY, Um JY, Hong SH, Kim HM: Epigallocatechin-3-gallate inhibits secretion of TNF-Alpha, IL-6 and IL-8 through the attenuation of ERK and NF-kappa B in HMC-1 cells. Int Arch Allergy Appl Immunol 2007;142:335-344
41. Yun HJ, Yoo WH, Han MK, Lee YR, Kim JS, Lee SI: Epigallocatechin-3- gallate suppresses TNF-Alpha-induced production of MMP-1 and-3 in rheumatoid arthritis synovial fibroblasts. Rheumatol Int 2008;29:23-29
42. Jiang J, Mo ZC, Yin K, Zhao GJ, Lv YC, Ouyang XP, Jiang ZS, Fu YC, Tang CK: Epigallocatechin-3-gallate prevents TNFalpha-induced NF-kappa B activation thereby upregulating ABCA1 via the Nrf2/Keap1 pathway in macrophage foam cells. Int J Mol Med 2012;29:946-956
43. Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G: Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Design 2010;16:1941-1951